The developer hopes for an early registration of "Sputnik V" in WHO

This, according to Interfax, said the head of the laboratory of mechanisms of population variability of pathogenic microorganisms of the Center.

Gamalei Vladimir Gushchin.

“The question with WHO is actually a question of submitting documents and adopting the procedure that we have established in Russia, and recognizing it by WHO.

Now we are actually at the finish line, the dialogue has been built, ”he said.

Earlier, the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said that the Sputnik V vaccine would be approved by WHO in the next couple of months.

On October 26, General Director of Generium, Daniil Talansky, said the firm had applied for clinical trials of a nasal form of the Sputnik V coronavirus vaccine.